General Director of JSC "Avva Rus" Alexey Egorov on the role of the "bank cleansing" of the Central Bank in business development in the Russian Federation
"Business undoubtedly suffers losses from such bank sanations, as all the funds held in accounts are lost," states Alexey Egorov, General Director of the pharmaceutical company "AVVA RUS".
Even in a situation where compensation for companies is introduced, 1.4 million rubles will not save the situation. It all boils down to companies opening accounts in banks with state participation: Sberbank, VTB... According to the expert, this will provide a guarantee for companies' capital, but this is a non-market mechanism.
So, questions truly remain for the Central Bank (CB). Who personally among the CB employees should be held responsible for such banks? After all, the CB's apparatus is sufficient to promptly identify problematic bank assets and prevent the situation from developing to the point of license revocation?
Quite significant budgetary funds are spent on maintaining the CB and monitoring financial markets. What is the reason that we learn about problems only when the bank's assets have already been moved outside the Russian Federation and the CB announces the revocation of the license? In such a situation, business will lose money and turn to state banks, as it has no other choice.
Preparations of our production:
On prescription:
Azithromycin Ecomed® tablets 500 mg , Amoxicillin Ekobol® tablets 250 mg , Amoxicillin Ekobol® tablets 500 mg , Amoxicillin tablets 250 mg , Amoxicillin tablets 500 mg , Amiodarone tablets 200 mg , Verapamil tablets 80 mg
Over the counter:
Media Contacts
Subscribe to get the latest news and articles
